The Zeltia Group Reports Financial Results for the First Six Months of 2013 .
*.- Gross Yondelis® sales rose by 13.3% compared with the first half of 2012 .
*.- Gross sales of Yondelis® also advanced by 11% compared with the first quarter of this year thanks to the restoration of the supply of Caelyx ® .
Madrid, 23 July 2013:
The Zeltia Group, today announced financial results for the first half of 2013. *.- Gross Yondelis® sales rose by 13.3% compared with the first half of 2012 .
*.- Gross sales of Yondelis® also advanced by 11% compared with the first quarter of this year thanks to the restoration of the supply of Caelyx ® .
Madrid, 23 July 2013:
Gross sales of oncology drug Yondelis® rose by 13.3% compared to the same period in 2012.
This improvement was largely attributable to the restoration of the Caelyx
® supply, which had not been available since September 2011. Yondelis® is administered in combination with Caelyx® for the treatment of ovarian cancer. In 1H13, net sales of Yondelis® rose by 8% on a year over year basis, including price discounts applied by different European countries.
The gradual recovery of Yondelis ® sales was one of several factors that shaped the first-half results of the Zeltia Group. Also noteworthy is the 11% growth in gross sales between the first and second quarter of this year Sales in the consumer chemicals segment were again impacted by the consumer spending crisis, which, along with the poor weather in the first half, resulted in a 10.69% decline in net sales.
Total Group net sales in the first half of 2013 were 71.3 million euro compared with 72.7 million euro in the same period last year.
Group EBITDA in 1H13 was 19.6 million euro compared to. 20.8 million euro in 1H12 from continuing activities).With the Group’s greater focus in oncology, total net income attributable to the parent company was 14.4 million euro compared to 11.2 million euro in 1H1, translating to a 28% increase year over year.
Zeltia Group reduced its overall financial debt for the eleventh consecutive quarter. In June 30 2013, the Group reported gross debt of 104.6 million euro, 9.6 million euro less than at the start of 2013.